VIVI — TempraMed Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for TempraMed Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.053	0.021	0.953
Net Total Accounts Receivable
Net Total Receivables	0.027	0.165	0.21
Total Inventory
Total Current Assets	0.263	0.266	1.52
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.241	0.201	0.324
Other Long Term Assets
Total Assets	0.506	0.469	1.84
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.55	3.52	3
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	2.16	4.27	3.72
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.65	-3.8	-1.88
Total Liabilities & Shareholders' Equity	0.506	0.469	1.84
Total Common Shares Outstanding